| 000 | 01577 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514215740.0 | ||
| 264 | 0 | _c20050929 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/s00125-004-1652-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOlesen, P | |
| 245 | 0 | 0 |
_aArterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. _h[electronic resource] |
| 260 |
_bDiabetologia _cMar 2005 |
||
| 300 |
_a561-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
| 650 | 0 | 4 | _aAutopsy |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xphysiopathology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aGlycoproteins _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xphysiopathology |
| 650 | 0 | 4 | _aOsteoprotegerin |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xblood |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xblood |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 | _aUmbilical Veins |
| 700 | 1 | _aLedet, T | |
| 700 | 1 | _aRasmussen, L M | |
| 773 | 0 |
_tDiabetologia _gvol. 48 _gno. 3 _gp. 561-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-004-1652-8 _zAvailable from publisher's website |
| 999 |
_c15376657 _d15376657 |
||